Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitorMichele S. Redell, David J. Tweardy|Blood|2011Cited by 261
DOT1L Inhibition Sensitizes MLL-Rearranged AML to ChemotherapyWei Liu, Michele S. Redell|PLoS ONE|2014Cited by 73
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well ToleratedAlexandra M. Stevens, Michele S. Redell|Cancers|2023Cited by 18
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemiaMichele S. Redell|Clinical & Translational Oncology|2021Cited by 8